Betting on biogenerics

被引：12

作者：

Dove, A

机构：

来源：

NATURE BIOTECHNOLOGY | 2001年 / 19卷 / 02期

关键词：

D O I：

10.1038/84365

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

With patents on several blockbuster therapeutic proteins soon to expire and several companies pondering whether to manufacture their own versions of these medicines, can a commercially viable business be based on biogenerics?.

引用

页码：117 / 120

页数：4

共 50 条

[41] Guides and medicine based on generics and biogenerics?
Gurfinkel, Enrique P.
[J]. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2011, 40 (01): : 3 - 4
[42] Teva to acquire Chinese biogenerics manufacturer
Katsnelson, A
[J]. NATURE BIOTECHNOLOGY, 2005, 23 (07) : 765 - 765
[43] Pharma swept up in biogenerics gold rush
Ratner, Mark
[J]. NATURE BIOTECHNOLOGY, 2009, 27 (04) : 299 - 301
[44] Betting
Pina, Cristina
[J]. HISPAMERICA-REVISTA DE LITERATURA, 2022, 51 (153): : 55 - 55
[45] BETTING
PEDERSEN, N
[J]. BULLETIN OF THE BRITISH PSYCHOLOGICAL SOCIETY, 1979, 32 (JUL): : 294 - 295
[46] Do betting costs explain betting biases?
Paton, D
Williams, LV
[J]. APPLIED ECONOMICS LETTERS, 1998, 5 (05) : 333 - 335
[47] 'Biogenerics': the off-patent biotech products
Schellekens, H
Ryff, JC
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (03) : 119 - 121
[48] Biocon, Mylan in pan-biogenerics deal
Killugudi Jayaraman
[J]. Nature Biotechnology, 2009, 27 (9) : 786 - 786
[49] Pharma swept up in biogenerics gold rush
Mark Ratner
[J]. Nature Biotechnology, 2009, 27 : 299 - 300
[50] Permutation Betting Markets: Singleton Betting with Extra Information
Ghodsi, Mohammad
Mahini, Hamid
Mirrokni, Vahab S.
Zadimoghaddam, Morteza
[J]. ALGORITHMICA, 2011, 60 (04) : 853 - 876

← 1 2 3 4 5 →